Star Health CEO Anand Roy expects the National Health Claims Exchange (NHCX) to simplify insurance claims like UPI did for payments. Amid this push, the company posted a Q1 FY2027 net profit of ₹550 crore. The focus remains on growing retail health insurance while managing rising hospital costs.
Star Health and Allied Insurance is pushing for the adoption of the National Health Claims Exchange (NHCX), a new platform that CEO Anand Roy believes could simplify health insurance claims in the same way the Unified Payments Interface (UPI) revolutionized digital money transfers in India. By creating a unified link between hospitals and insurers, the platform aims to reduce the paperwork and time currently required for claims settlement, as hospitals would need to integrate with only one central system instead of multiple insurance providers.
This strategic focus on technology coincides with a period of financial growth for the company. For the first quarter of the 2027 fiscal year, Star Health reported a net profit of ₹550 crore, marking a 25% increase compared to the same period last year. The stock has been trading in the ₹575–₹585 range as of August 20, 2026.
A key part of the company's current business model is its heavy shift toward retail health insurance, which now makes up the vast majority of its operations. The company has moved away from large corporate accounts that were previously less profitable to help stabilize its margins. Its operations are also becoming faster, with the company currently handling 81% of its claims via a cashless system, and 90-93% of these claims being approved within one hour.
Despite the growth, the health insurance sector faces pressure from rising hospital costs. Medical inflation remains a challenge, as increasing treatment prices can strain the company's profit margins if insurance premiums cannot be adjusted accordingly. Additionally, the industry has experienced occasional friction regarding hospital tariffs and billing standards. While the company is promoting the use of standard treatment protocols to help manage these costs, the ability to balance affordable premiums with rising medical expenses remains a critical factor for the business.
Investors may watch how quickly the company scales the use of the NHCX platform, as broader adoption could further improve operational efficiency and potentially reduce administrative costs. The management's ability to maintain high retail growth while navigating the broader healthcare pricing environment will also be important to track in the coming quarters.